Healio

Denosumab use for osteoporosis may also lower risk for diabetes

Please provide your email address to receive an email when new articles are posted on . Adults with osteoporosis who received more than one dose of denosumab had a reduced risk for developing diabetes ...
Healio

Lack of osteoporosis knowledge despite high prevalence among postmenopausal women

Please provide your email address to receive an email when new articles are posted on . More than half of participants had osteoporosis with a trend of prevalence increasing with age. Women in Tianjin ...
Free Malaysia Today on MSN

Osteoporosis: the silent threat you can prevent early

This condition weakens bones without warning, but simple lifestyle changes, screening, and nutrition can protect mobility and independence.
Medscape

Lower Diabetes Risk Linked to Osteoporosis Drug Denosumab

Continued denosumab treatment is associated with a lower risk for diabetes in adults with osteoporosis older than 65 years, found a large-scale cohort study in Taiwan. Denosumab, used in osteoporosis ...

Mabxience And Amneal Announces FDA Approval Of Denosumab Biosimilars Referencing Prolia® And XGEVA®

Mabxience And Amneal Announces FDA Approval Of Denosumab Biosimilars Referencing Prolia® And XGEVA®. mAbxience / Key word(s): Miscellaneous mAbxience and Amneal Announces FDA Approval of Denosumab ...

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

Approvals expand Amneal’s biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by 2027BRIDGEWATER, ...